Paratek Pharmaceuticals, Inc.
PRTKDelisted Sep 21, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001178711
Paratek Pharmaceuticals, Inc. was delisted on Sep 21, 2023; its insiders filed their last Form 4 on Sep 21, 2023; 66 institutions reported holding it in 13F filings for Q2 2023, worth $47.0M in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in Paratek Pharmaceuticals, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 103
- −1 vs. Q3 2021
- Shares held
- 25.4M
- +1.47M (+6.2%) vs. Q3 2021
- Total value
- $114.1M
- −$2.35M (−2.0%) vs. Q3 2021
- New holders
- 10
- 37 more added
- Sold out
- 11
- 37 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PRTK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 66 | $47.0M |
| Q1 2023 | 63 | $59.1M |
| Q4 2022 | 76 | $42.6M |
| Q3 2022 | 72 | $59.8M |
| Q2 2022 | 84 | $44.4M |
| Q1 2022 | 100 | $82.1M |
| Q4 2021 | 103 | $114.1M |
| Q3 2021 | 105 | $116.5M |
| Q2 2021 | 116 | $166.5M |
| Q1 2021 | 107 | $169.4M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Paratek Pharmaceuticals, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 2,161,773 | $9.71M | 0.00% | −450.0% | Reduced |
| AIGH Capital Management LLC | 2,339,107 | $10.5M | 3.29% | +729,709+45.3% | Added |
| BlackRock Inc. | 2,977,680 | $13.4M | 0.00% | +60,540+2.1% | Added |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −111,547−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −24,392−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −22,313−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −20,379−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −19,182−100.0% | Sold out |
| Summit Global Investments | 0 | $0 | 0.00% | −18,600−100.0% | Sold out |
| Kalos Management, Inc. | 0 | $0 | 0.00% | −15,550−100.0% | Sold out |
| Essex Financial Services, Inc. | 0 | $0 | 0.00% | −13,800−100.0% | Sold out |
| Jaffetilchin Investment Partners, LLC | 0 | $0 | 0.00% | −12,675−100.0% | Sold out |
| Toth Financial Advisory Corp | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −1,110−100.0% | Sold out |
| HighPoint Advisor Group LLC | – | – | – | – | Not filed |